Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Makhnin, Alex
16  Ergebnisse:
Personensuche X
?
1

Author Correction: Identification of optimal dosing schedul..:

Poels, Kamrine E. ; Schoenfeld, Adam J. ; Makhnin, Alex...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
2

Corrigendum to "Clinical utility of next-generation sequenc..:

Mondaca, Sebastian ; Lebow, Emily S. ; Namakydoust, Azadeh...
Lung Cancer.  162 (2021)  - p. 210 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Identification of optimal dosing schedules of dacomitinib a..:

Poels, Kamrine E. ; Schoenfeld, Adam J. ; Makhnin, Alex...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
4

Clinical utility of next-generation sequencing-based ctDNA ..:

Mondaca, Sebastian ; Lebow, Emily S. ; Namakydoust, Azadeh...
Lung Cancer.  159 (2021)  - p. 66-73 , 2021
Link: https://doi.org/10.1016/..
 
?
5

A Prospective Study of Circulating Tumor DNA to Guide Match..:

Sabari, Joshua K ; Offin, Michael ; Stephens, Dennis...
JNCI: Journal of the National Cancer Institute.  111 (2018)  6 - p. 575-583 , 2018
Link: https://doi.org/10.1093/..
 
?
6

Author Correction: Identification of optimal dosing schedul..:

Poels, Kamrine E ; Schoenfeld, Adam J ; Makhnin, Alex...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508237/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Identification of optimal dosing schedules of dacomitinib a..:

Poels, Kamrine E ; Schoenfeld, Adam J ; Makhnin, Alex...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211846/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Pilot Study of Dacomitinib for Patients With Metastatic EGF..:

Choudhury, Noura J ; Makhnin, Alex ; Tobi, Yosef Y...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232442/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Clinical utility of next-generation sequencing-based ctDNA ..:

Mondaca, Sebastian ; Lebow, Emily S ; Namakydoust, Azadeh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594131/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Corrigendum to "Clinical utility of next-generation sequenc..:

Mondaca, Sebastian ; Lebow, Emily S ; Namakydoust, Azadeh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551809/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Erlotinib and Trametinib in Patients With EGFR-Mutant Lung ..:

Luo, Jia ; Makhnin, Alex ; Tobi, Yosef...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232136/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Effect of Osimertinib and Bevacizumab on Progression-Free S..:

Yu, Helena A ; Schoenfeld, Adam J ; Makhnin, Alex...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256866/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

MET exon 14-altered lung cancers and MET inhibitor resistan..:

Guo, Robin ; Offin, Michael ; Brannon, A. Rose...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854494/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Lessons learned from routine, targeted assessment of liquid..:

Mondaca, Sebastian ; Offin, Michael ; Borsu, Laetitia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480496/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

Author Correction: Identification of optimal dosing schedul..:

Kamrine E. Poels ; Adam J. Schoenfeld ; Alex Makhnin...
https://doi.org/10.1038/s41467-022-33355-0.  , 2022
Link: https://doi.org/10.1038/..
 
1-15